changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Please find below a list of our press releases.
8 Jul 2013
On 23 May 2013, BTG plc (BTG or the Company), the specialist healthcare company, announced that it had entered into an agreement to buy EKOS Corporation (EKOS) conditional on Hart-Scott-Rodino (HSR) approval in the US.
23 May 2013
BTG plc is pleased to announce that it has entered into an agreement to buy EKOS Corporation.
12 Apr 2013
BTG plc, announces that the New Drug Application (NDA) seeking approval of Varisolve® as a comprehensive treatment for varicose veins, which was submitted to the US Food & Drug Administration (FDA) on 4 February 2013, has been accepted for full review by the FDA.
4 Feb 2013
BTG plc today announces that a New Drug Application (NDA) seeking approval of Varisolve® (polidocanol endovenous microfoam (PEM)) as a comprehensive treatment for varicose veins has been submitted to the US Food & Drug Administration (FDA).